Growth Metrics

Vanda Pharmaceuticals (VNDA) Gross Profit Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.76%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 16.94%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 2,488.21%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn 4.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.38%
Dec 31, 2025 5.51%
Sep 30, 2025 18.19%
Jun 30, 2025 4.43%
Mar 31, 2025 5.67%
Dec 31, 2024 21.01%
Sep 30, 2024 26.15%
Jun 30, 2024 12.18%
Mar 31, 2024 -23.74%
Dec 31, 2023 -28.21%
Sep 30, 2023 -39.40%
Jun 30, 2023 -27.04%
Mar 31, 2023 5.86%
Dec 31, 2022 -5.73%
Sep 30, 2022 -6.79%
Jun 30, 2022 -4.89%
Mar 31, 2022 -3.73%
Dec 31, 2021 0.89%
Sep 30, 2021 16.34%
Jun 30, 2021 8.82%
Mar 31, 2021 7.29%
Dec 31, 2020 11.95%
Sep 30, 2020 3.24%
Jun 30, 2020 6.96%
Mar 31, 2020 23.93%
Dec 31, 2019 15.47%
Sep 30, 2019 19.60%
Jun 30, 2019 25.05%
Mar 31, 2019 9.14%
Dec 31, 2018 19.98%
Sep 30, 2018 19.71%
Jun 30, 2018 12.28%
Mar 31, 2018 16.82%
Dec 31, 2017 19.75%
Sep 30, 2017 16.89%
Jun 30, 2017 27.06%
Mar 31, 2017 22.36%
Dec 31, 2016 28.41%
Sep 30, 2016 44.23%
Jun 30, 2016 35.38%
Mar 31, 2016 59.36%
Dec 31, 2015 74.82%
Sep 30, 2015 55.08%
Jun 30, 2015 104.58%